Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
Public ClinicalTrials.gov record NCT00931918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with or without VELCADE in adult patients with previously untreated non-(Germinal B-Cell-like) GCB Diffuse Large B-cell Lymphoma (DLBCL). The study will determine whether the addition of VELCADE to RCHOP improves progression-free survival (PFS) in patients with non-GCB DLBCL.
Study identification
- NCT ID
- NCT00931918
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 206 participants
Conditions and interventions
Interventions
- Bortezomib Drug
- Rituximab Drug
- Cyclophosphamide Drug
- Doxorubicin Drug
- Vincristine Drug
- Prednisone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2009 (Type not available)
- Primary completion
- Aug 2015 (Actual)
- Completion
- Aug 2015 (Actual)
- Last update posted
- Jan 11, 2017
2009 – 2015
United States locations
- U.S. sites
- 70
- U.S. states
- 24
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tower Cancer Research Foundation | Beverly Hills | California | 90211 | — |
| Fountain Valley Regional Hospital | Fountain Valley | California | 92708 | — |
| St. Jude Heritage Healthcare | Fullerton | California | 92835 | — |
| Moores Cancer Center- UCSD | La Jolla | California | 92093 | — |
| Antelope Valley Cancer Center | Lancaster | California | 93534 | — |
| Loma Linda University Cancer Center | Loma Linda | California | 92354 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Jonsson Comprehensive Cancer Center | Los Angeles | California | 90095 | — |
| TORI- Central Pharmacy | Los Angeles | California | — | — |
| TORI- Central Regulatory | Los Angeles | California | — | — |
| Oncology Care Medical Associates | Montebello | California | 90640 | — |
| Bay Area Cancer Research Group | Pleasant Hill | California | 94523 | — |
| Wilshire Oncology Medical Group | Rancho Cucamonga | California | 91730 | — |
| Sharp Healthcare | San Diego | California | 32123 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33619 | — |
| Florida Cancer Specialists & Research Institute | Gainsville | Florida | 32605 | — |
| Alves/ Domenech Oncology-Hematology Clinic | Hollywood | Florida | 33019 | — |
| Florida Cancer Institute ATI | New Port Richey | Florida | 34655 | — |
| MD Anderson Cancer Center of Orlando | Orlando | Florida | 32806 | — |
| Coastal Oncology, PL | Ormond Beach | Florida | 32174 | — |
| Winship Cancer Institute at Emory University | Atlanta | Georgia | 30322 | — |
| Georgia Cancer Specialists | Atlanta | Georgia | 30341 | — |
| Dublin Hematology and Oncology | Dublin | Georgia | 31021 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Central Indiana Cancer Centers | Fishers | Indiana | 46227 | — |
| Cancer Care Center Inc. P.C. | New Albany | Indiana | 47150 | — |
| Iowa Blood and Cancer Care | Cedar Rapids | Iowa | 52401 | — |
| Iowa Oncology Research Association | Des Moines | Iowa | 50309 | — |
| Siouxland Hematology and Oncology Associates LLP | Sioux City | Iowa | 51101 | — |
| Kansas City Cancer Center, LLC | Overland Park | Kansas | 66210 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| St. Agnes Hospital of Baltimore | Baltimore | Maryland | 21229 | — |
| Holy Cross Hospital | Silver Spring | Maryland | 20910 | — |
| Lahey Clinic Medical Center | Burlington | Massachusetts | 01805 | — |
| Berkshie Hematology Oncology | Pittsfield | Massachusetts | 01201 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Mid Michigan Physicians | Lansing | Michigan | 48912 | — |
| Duluth Clinic | Duluth | Minnesota | 55805 | — |
| St. Luke's Hospital Cancer Care Center | Duluth | Minnesota | 55805 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| Saint Luke's Cancer Institute | Kansas City | Missouri | 64111 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Hematology/Oncology Associates of Northern New Jersey, P.A. | Morristown | New Jersey | 07962 | — |
| Hematology Oncology Associates of South Jersey | Mount Holly | New Jersey | 08060 | — |
| St. Luke's- Roosevelt Medical Center | New York | New York | 10019 | — |
| Cornell | New York | New York | — | — |
| Raleigh Hematology Oncology Associates P.C. | Raleigh | North Carolina | 27607 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45267 | — |
| Kaiser Group Health | Portland | Oregon | 97227 | — |
| Hematology and Oncology Associates of NEPA | Dunmore | Pennsylvania | 18512 | — |
| UPMC Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Guthrie Clinic | Sayre | Pennsylvania | 18840 | — |
| Berks Hematology Oncology Associates | West Reading | Pennsylvania | 19611 | — |
| South Carolina Oncology Associates, PA | Columbia | South Carolina | 29201 | — |
| Chattanooga Oncology and Hematology Associates, PC | Chattanooga | Tennessee | 37404 | — |
| Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Texas Oncology Cancer Center | Austin | Texas | 78731 | — |
| US Oncology- Central Drug | Fort Worth | Texas | 76177 | — |
| US Oncology- Central Laboratory | Fort Worth | Texas | 76177 | — |
| Oncology Consultants P.A. | Houston | Texas | 77024 | — |
| Oncology Consultants | Houston | Texas | 77030 | — |
| US Oncology- Central Regulatory | The Woodlands | Texas | 77380 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texoma Cancer Center | Wichita Falls | Texas | 76310 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | — |
| Puget Sound Cancer Centers | Edmonds | Washington | 98026 | — |
| Northwest Cancer Specialists PC | Vancover | Washington | 98686 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00931918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00931918 live on ClinicalTrials.gov.